Yoshimi Kiyozumi

发表

Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.

T. Sugino, H. Kenmotsu, S. Nishimura, 2022, Japanese journal of clinical oncology.

Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients

K. Yamaguchi, T. Nagashima, M. Kusuhara, 2020, Human Genetics.

A Cross-sectional Study of Regret in Cancer Patients After Sharing Test Results for Pathogenic Germline Variants of Hereditary Cancers With Relatives.

K. Yamaguchi, M. Kusuhara, S. Nishimura, 2023, Cancer nursing.

Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type.

T. Sugino, H. Ono, K. Hotta, 2022, Human pathology.

Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses

H. Ono, K. Hotta, Y. Hirashima, 2022, BMC Cancer.

A novel MLH1 intronic variant in a young Japanese patient with Lynch syndrome

K. Yamaguchi, M. Kusuhara, S. Ohnami, 2018, Human Genome Variation.

Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients

H. Ono, S. Nishimura, T. Sugiura, 2022, Journal of Human Genetics.

A Japanese case of familial malignant melanoma with germline CDK4 variant incidentally diagnosed by cancer genome profiling

S. Nishimura, Y. Kiyohara, H. Matsubayashi, 2023, Journal of Human Genetics.

A Japanese Family Meeting the Clinical Diagnostic Criteria for MEN1 with a MEN1 Variant of Uncertain Significance

K. Nakashima, S. Nishimura, H. Ishiwatari, 2023, Internal medicine.

The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review.

K. Uesaka, H. Ishiwatari, A. Todaka, 2024, Familial cancer.